| Code | 1376E | ||||||||||
| MA number | 50/0181/22-S | ||||||||||
| Product Form: | tbl flm 30x25 mg (blis.PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 50 - DIURETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.07.2022 |
| Validity: | 29.07.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Spironolactone Medreg_tbl flm_08_2023.pdf
|
| PIL: |
PIL_Spironolactone Medreg_tbl flm_01_2024.pdf
|
| Safety feature | Yes |
| Data update: | 02.08.2022 |
